FibroBiologics, Inc. share price logo

FibroBiologics, Inc.

NASDAQ: FBLG

$1.10

-0.03

(-2.65%)

Live

as on

FibroBiologics, Inc. Stock Performance

as on October 13, 2026 at 1:07 am IST

  • Day's High

    $1.10
    $1.13

    2.73%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.62
    $9.65
    downward going graph

    43.63%

    Downside

    777.64%

    Upside

    downward going graph

FibroBiologics, Inc. share price movements today

Previous Close
$1.13
Open
$1.13
Volume
21.1K
Market Cap
$8.0M
Day's Low - High
$1.10 - $1.13
52 Week Low - High
$0.62 - $9.65

FibroBiologics, Inc. Historical Returns

1 Month Return
-29.81 %
3 Month Return
+ 23.27 %
1 Year Return
-87.49 %
3 Year Return
0 %
5 Year Return
0 %

FibroBiologics, Inc. Stock Fundamentals & Key Indicators

Check FibroBiologics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.0M

EPS (TTM)

-6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.19

Industry PE ratio

-3.05

PEG Ratio

0.27

EBITDA

-17.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-536.78%

FibroBiologics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of FibroBiologics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$8.0MNA-0.190.00%0.00%
Neutral$89.8B-27.68%-28.20-12.57%0.00%
StrongBuy$129.3B183.05%29.4586.04%0.00%
Buy$76.9B37.12%17.8384.86%0.50%

Stock Returns calculator for FibroBiologics, Inc. Stock including INR - Dollar returns

The FibroBiologics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

FibroBiologics, Inc. investment value today

Current value as on today

₹13,151

Returns

-₹86,849

(-86.85%)

Returns from FibroBiologics, Inc. Stock

-₹87,824 (-87.82%)

Dollar Impact

₹974 (+0.97%)

Analyst Recommendation on FibroBiologics, Inc. Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for FibroBiologics, Inc.. Average target price of $6

FibroBiologics, Inc. Share Price Target

Get share price movements and forecasts by analysts on FibroBiologics, Inc..

Current Price

$1.1

Analyzed by

1 Analysts

High

$6

0

Low

$6

FibroBiologics, Inc. target price $0, a slight upside of 0% compared to current price of $1.1. According to 1 analysts rating.

Indian Investors' Interest in FibroBiologics, Inc. Stock

Search interest for FibroBiologics, Inc. Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-72% versus previous 30 day period

FibroBiologics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
0
-
-
Operating Income
-2
-3
-3
-3
-4
-4
-5
-2
-5
-4
EBITDA
-9
-8
1
0
-4
-4
-5
-2
-4
-3
Interest Expense
0
0
0
0
-
-
-
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-9
-8
0
0
-4
-4
-5
-3
-5
-4
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-9
-8
0
0
-4
-4
-5
-3
-5
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

FibroBiologics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
0
Operating Income
-1
-1
-4
-8
-13
-16
EBITDA
-
-1
-4
-15
-10
-17
Interest Expense
-
0
0
0
0
0
Depreciation
1
-
0
0
0
0
Income Before Tax
-1
-1
-5
-16
-11
-18
Income Tax Expense
-
-
-
-
-
-
Net Income
-1
-1
-5
-16
-11
-18
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

FibroBiologics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-8
0
0
-4
-4
-5
-3
-5
-4
Operating Cash Flow
-1
-4
-1
-2
-5
-3
-3
-3
-4
-3
Investing Cash Flow
0
0
0
0
0
0
0
-
-
-
Financing Cash Flow
-
3
0
4
-
4
-
3
0
5
Change in Cash
-1
-1
-2
1
-5
0
-3
0
-3
2

FibroBiologics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
-1
-1
-5
-16
-11
-18
Operating Cash Flow
-1
-1
-4
-6
-11
-16
Investing Cash Flow
-
-
-
0
0
0
Financing Cash Flow
1
1
5
13
16
7
Change in Cash
-
0
1
6
4
-9

Global Institutional Holdings in FibroBiologics, Inc.

Check out the Institutions with significant holdings in FibroBiologics, Inc..

Funds
Holdings
VANGUARD INDEX FUNDS
1.02%
Becky Wood
0.78%
Vanguard
0.42%
MORGAN STANLEY PATHWAY FUNDS
0.02%
ProFunds
0.01%

FibroBiologics, Inc. News & Key Events

  • img

    Today's Timeline - 07 October

    Wed, 06:00 PM

    -

    FibroBiologics files U.S. patent for cell-based technology to produce peptides like GLP-1 inside the body.

Insights on FibroBiologics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 826.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, FBLG stock has moved down by -29.8%

About FibroBiologics, Inc.

FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.
OrganisationFibroBiologics, Inc.
Headquarters455 East Medical Center Boulevard, Houston, TX, 77598, US
IndustryBiotechnology
CEOPeter O'Heeron

Key Management of FibroBiologics, Inc.

Name

Title

Mr. Ruben A. Garcia J.D.

General Counsel

Mr. Jason D. Davis CPA

Chief Financial Officer

Mr. Peter O'Heeron

Founder, Chairperson & CEO

Dr. Hamid Khoja Ph.D.

Chief Scientific Officer

FAQs

What is FibroBiologics, Inc. share price today?

FibroBiologics, Inc. share price today is $1.10 as on . FibroBiologics, Inc. share today touched a day high of $1.13 and a low of $1.10.

What is the 52 week high and 52 week low for FibroBiologics, Inc. share?

FibroBiologics, Inc. share touched a 52 week high of $9.65 on and a 52 week low of $0.62 on . FibroBiologics, Inc. stock price today i.e. is trending at $1.10,which is 88.61% down from its 52 week high and 77.39% up from its 52 week low.

What is FibroBiologics, Inc.'s market capitalisation today?

FibroBiologics, Inc. market capitalisation is $0.00T as on .

How to invest in FibroBiologics, Inc. Stock (FBLG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for FibroBiologics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy FibroBiologics, Inc. Stock (FBLG) from India?

Indian investors can start investing in FibroBiologics, Inc. (FBLG) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in FibroBiologics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on FibroBiologics, Inc. share’s latest price of $1.10 as on October 12, 2026 at 7:37 pm IST, you will get 9.0909 shares of FibroBiologics, Inc.. Learn more about fractional shares .